Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine

Published:2019-08-23 Issue:9 Volume:30 Page:2300-2311
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Pearce Amanda K.¹^ORCID,O’Reilly Rachel K.¹^ORCID

Affiliation:

1. School of Chemistry, University of Birmingham, Edgbaston, Birmingham B15 2TT, United Kingdom

Funder

H2020 European Research Council

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.9b00456

Reference99 articles.

1. The journey of a drug-carrier in the body: An anatomo-physiological perspective

2. Nanomedicine of synergistic drug combinations for cancer therapy – Strategies and perspectives

3. Estimation of clinical trial success rates and related parameters

4. Impact of Nanotechnology on Drug Delivery

5. Cancer nanomedicine: from targeted delivery to combination therapy

Cited by 192 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel paradigm of therapeutic intervention for skin cancer: challenges and opportunities;Future Journal of Pharmaceutical Sciences;2024-09-02

2. Sequential catalytic nanomedicinal utilization for synergistic drug delivery application in cancer nanotechnology;Journal of Molecular Structure;2024-09

3. AC099850.3 promotes HBV-HCC cell proliferation and invasion through regulating CD276: a novel strategy for sorafenib and immune checkpoint combination therapy;Journal of Translational Medicine;2024-08-31

4. Design and translation of injectable biomaterials;Nature Reviews Bioengineering;2024-08-28

5. Recent advances in nano-based drug delivery systems for treatment of liver cancer;Journal of Pharmaceutical Sciences;2024-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3